Concateno acquires Medscreen Holdings
Clients Concateno plc
Jones Day advised Concateno plc, a leading drug and alcohol testing provider and a manufacturer of clinical diagnostic products, in connection with its acquisition of Medscreen Holdings Limited, a global provider of drugs and alcohol testing services. The acquisition, which constituted a reverse takeover, was funded through a combination of a placing to raise £18.7 million ($37 million), new debt facilities and existing cash resources. The total consideration was £30 million ($60 million).